Distal Protection Devices During Primary Angioplasty in Acute Myocardial Infarction

YAO Ying-jie,YANG Yan-min,WANG Xu

DOI: https://doi.org/10.3969/j.issn.1004-3934.2006.06.010

2006-01-01

Abstract:Distal embolization and no-flow phenomenon are important aspects of interventional therapy.Distal protection devices can reduce this phenomenon.This article summarizes the role of distal protection device.

What problem does this paper attempt to address?

Effect of a Distal Protection Device on Epicardial Blood Flow and Myocardial Blush in Primary Percutaneous Coronary Intervention

ZHOU Bin-quan,Fu Guo-shen

DOI: https://doi.org/10.3760/j.issn:1671-0282.2007.06.008

2007-01-01

Abstract:Objective To study the effect of a distal protection device (Pereusurge GuardWire: GW) on epicardial blood flow and myocardial perfusion in primary percutaneous coronary intervention. Method Acute STEMI patients treated with primary PCI were eligible to be studied. Inclusion criteria were: (1) within 12 hours from the onset of chest pain;(2) culprit leision with diameter stenosis≥70% and TIMI flow grade≤2. Exclusion criteria were:(1) patients undergoing thrombolytic therapy before PCI; (2) a culprit lesion in the left main coronary artery;(3)reference vessel diameter3.0 mm;(4) KillipⅣor cardiogenic shock. The 116 consecutive patients with AMI were randomly divided into, the GW group and the control group. The GW group included 56 patients with AMI who underwent primary PCI with GW protection, and the control group included 60 patients who underwent primary PCI without GW protection. The antagonist of GpⅡb/Ⅲa receptor did not employ during perioperation period. If the infarct-related artery (IRA) was the right coronary artery, the occlusion balloon was positioned at distal end of the right coronary artery and just prior to the bifurcation. If IRA was left anterior descending (LAD), the occlusion balloon was placed at the distal part of mid LAD. If the IRA was (LCX), the oechsion balloon was inserted in researching the midportion of LCX. The catheter fur aspiration was used to remove the thrombus and debris of plaque by laraging forward for and backward for several times before lesion dilatation. Epicardial blood flow IRA and myocardial perfusion were evaluated according to the thrombolysis in myocardial infarction (TIMI) flow grade and the myocardial blush grade (MBG). Results The rate of TIMI score of 3 was significantly higher in the GW group (96%) than in the control group (80%). The rate of MBG score of 3 was obtained also significantly greater in the GW group (64%) than in the control group (33%). Conclusions primary PCI with GW protection can significantly improve epicardial blood flow and myocardial perfusion.
Clinical Observation of Distal Protection Device During Primary Angioplasty in Acute Myocardial Infarction

YAO Ying-jie,WANG Xu,SHAO Yi-bin,WANG Zheng-zhong,WANG Yan,YANG Yan-min,ZHANG Cun-quan

DOI: https://doi.org/10.3969/j.issn.1673-6273.2007.02.025

2007-01-01

Abstract:Objective To evaluate the safety and efficacy of distal protection device(GuardWire PlusTM) during high risk PCI in patients with acute myocardial infarction(AMI).Methods Seventy-two patients with AMI admitted from September 2004 to May 2006 who received PCI were categotized into the GuardWire PlusTM group(GW group,n=38) and the conventional guidewire group(NGW group,n=34) according to the device used.The basic clinical characteristics,angiographic results,degree ST of resolution and changes in serum CK-MB and cTnI levels were compared.LVEF was measured by echocardiography at discharge and again at 3 months after PCI.Results All the distal protection deveices were applied successfully in the GW group.A greater percentage of patients in the GW group had post procedural ST-segment resolution ≥50% compared with the NGW group(68.4% vs 41.2%,P0.05).The serum CK-MB reached its peak level at 8.63±2.42 h after onset in the GW group,and at 11.18±2.26 h after onset in the NGW group.The serum peak level of CK-MB was significantly lower in the GW group than that in the NGW group(63.3±9.82 ng/mL vs 74.28±6.15 ng/mL,P=0.000).The peak serum level of cTnI appeared at 10.16±2.96 h after onset in the GW group and at 12.35±2.06 h after onset in the NGW group.The serum peak level of cTnI was also significantly lower in the GW group than that in the NGW group(18.01±7.21 ng/mL vs 21.48±5.61 ng/mL,P=0.027).The left ventricular ejection fraction 3 months after discharge was higher in the GW group than that in the NGW group(57.82%±2.50% vs 55.09%±3.32%,P0.001).Conclusion It is feasible and safe to apply the GuardWire PlusTM distal protection device during PCI in AMI patients to prevent distal embolization,minimize the infarction size and increase LVEF.
Myocardial Protection in Patients with Acute Myocardial Infarction Using Distal Occlusion Balloon Protection Device

He Xinmin,Yang Xu,Zhu Hengli

DOI: https://doi.org/10.3969/j.issn.1006-7035.2008.05.002

2008-01-01

Abstract:Purpose:To evaluate myocardial protection of left ventricle function in patients with acute myocardial infarction(AMI)us- ing distal occlusion balloon protection devices by echocardiography.Materials and Methods:Twenty-two patients who had received percuta- neous coronary intervention(PCI)with distal protection devices were examined by echocardiograpliy before and after one,three and six months op- eration,so were thirty patients who had received traditional PCI as control group.Ejection fraction(EF),wall motion index(WMSI),left ven- tricular end-diastolic volume(LVEDV),and left ventricular end-systolic volume(LVESV)were measured in each patients.Results:There were no differences in each index between two groups preoperatively.Red or pale thrombus were aspirated in all patients using distal protection de- vices.Compared with control group,EF were significantly higher in each time point post-operatively,WMSI and LVEDV were significantly low- er after three and six months in distal protection devices group.The same result occurred in thromboysis in myocardial infaction(TIMI)flow grade between two groups.Conclusion:Myocardial perfusion and systolic function were improved using distal protection devices.The effect of myocar- dial protection could be monitoring and evaluation by echocardiography.
Application of the Vascular Distal Protection Device in Percutaneous Coronary Interventional Therapy in Patients with Acute ST Segment Elevation Myocardial Infarction

叶飞,陈绍良,马玉玲,林松,张俊杰,戴振林,段宝祥

DOI: https://doi.org/10.3969/j.issn.0253-3685.2004.10.001

2004-01-01

Abstract:Objective We tested the safety,feasibility,and efficacy of the PercuSurge guardwire,a kind of vascular distal protection devices(DPD),as an adjunct to primary percutaneous coronary intervention(PCI)during the treatment for patients with acute ST segment elevation myocardial infarction(STEMI).Methods 38 patients with acute STEMI were randomized into two groups which include a control group treated by primary PCI alone and PCI combined with DPD group.We compared coronary reperfusion flow(TIMI grades),TIMI myocardial perfusion(TMP grades) and prognosis during 30 days after the setting of acute STEMI between two groups.Results The average TIMI reperfusion grades of culprit coronary artery were 2.53±0.34 in PCI+DPD group which was better than that in PCI group(2.01±0.42),P0.05.TMP grades was 2.35±0.48 in PCI+DPD group which was better than PCI group(1.86±0.51),P0.05.Left ventricular ejection fraction in PCI+DPD group was higher than that of PCI group significantly(52±6% vs 46±5%,P0.05)at 30 days.But mortality has no difference between the two groups during 30 days after PCI.Conclusion The DPD is an intuitive,fast,safe,and effective alternative for the patients with acute STEMI which is better than PCI alone.
The Application of AngioguardTM Distal Protection Device in the Emergency Percutaneous Coronary Intervention in Patients with Acute ST Segment Elevation Myocardial Infarction

王乐丰,杨新春,佟子川,徐立,王红石,邹阳春,葛永贵,王立中,李惟铭,连勇,栾与英,吴兆苏,张维君,周旭

DOI: https://doi.org/10.3969/j.issn.1004-8812.2003.03.003

2003-01-01

Abstract:Objective To evaluate the feasibility of Angioguard TM DPD during emergency PCI in the patients with acute STEMI. Methods From July 2002 to Dec. 2002, 40 acute STEMI patients who received primary coronary intervention were included into this study. Patients were divided into two groups according to whether Angioguard TM DPD was attempted during emergency PCI. The basic clinical characteristics, angiographic results, and follow-up data before discharge were compared. TIMI grade, TIMI Frame Count and myocardial blush grade were performed in all cases after emergency PCI. Results Success was achieved in 19 patients (19/21, 90.4%) by Angioguard TM DPD with varies extent of material from the basket. There was no significant difference between the two groups in basic clinical characteristics, angiogram before PCI (P0.05) and TIMI 3 flows achieved in IRAs after PCI (100% vs 84%, P=0.23). Less distal embolizations (5.2% vs 36.8%, P=0.042), Better TIMI frame count (19.9±5.7 vs 30.3±9.6, P0.001) and better percentage of blush grade 3 of IRAs (73.7% vs 31.6%, P=0.022) were achieved in DPD group. Follow-up date before discharge showed there were lower peak serum CK levels, higher LVEF and faster ST segment resolution in the Angioguard TM group after PCI (P0.05). There was no MACE in both groups. Conclusion Application of Angioguard TM DPD during emergency PCI in some patients with acute STEMI was safe and effective which could improve distal coronary perfusion and left ventricular function. TIMI Frame Count and myocardial Blush grade in evaluation of distal myocardial blood perfusion during emergency PCI was superior to that of TIMI grade in this study.
Distal embolic filter protection during debulking treatment of peripheral artery disease

任碧晨,李小燕,刘浩,蒋小浪,鞠帅,陈斌,蒋俊豪,石赟,马韬,林长泼,郭大乔,徐欣,董智慧,符伟国

DOI: https://doi.org/10.3760/cma.j.cn113855-20211102-00624

2022-01-01

Abstract:Objective:To discuss the strategies of distal embolic filter protection(DEFP) during excimer laser ablation (ELA) or percutaneous mechanical thrombectomy (PMT) in treatment of peripheral artery disease.Methods:Clinical data of 29 patients undergoing ELA or PMT under the DEFP from Oct 2019 to Aug 2021 were retrospectively collected to analyze the strategies of DEFP and high-risk factors of capturing clinically significant macrodebris.Results:There were 21 males and 8 females, aged (70.3±11.0) years with 32 lesions (29 limbs) including 5 in-stent restenosis (ISR), 10 thrombosis and 17 chronic total occlusion (CTO). The technical success rate of DEFP device release and recovery was 100%. The overall debris capture rate was 77.3% and the macrodebris capture rate was 36.4%. Even with DEFP the distal embolization (DE) incidence was 3.4%. When ELA for CTO with severe calcification or long-segment ISR lesions, the capture rate of macrodebris was as high as 60.0%, and the former was significantly higher than ELA for CTO without high calcification lesions ( P<0.05). Conclusion:ELA or PMT under the DEFP in treatment of peripheral artery disease appears to be of great significance in preventing DE.
Effect of a Distal Protection Device on Epicardial Blood Flow and Myocardial Perfusion in Primary Percutaneous Coronary Intervention

Zhou Bin-quan,Tahk Seung-Jea

DOI: https://doi.org/10.1631/jzus.2007.b0575

2007-01-01

Abstract:OBJECTIVE:The beneficial effect of percutaneous coronary intervention (PCI) in patients with acute myocardial infarction (AMI) has been well established, but there is the problem of no-reflow phenomenon which is an adverse prognostic factor in primary PCI. In the present study the effect of a distal protection device (PercuSurge GuardWire; GW) on epicardial blood flow and myocardial perfusion was evaluated.METHODS AND RESULTS:Patients with AMI were randomly divided into 2 groups, the GW and the control groups. The GW group included 52 patients with AMI who underwent primary PCI with GW protection and the control group included 60 patients who underwent primary PCI without GW protection. Epicardial blood flow in the infarct-related artery (IRA) and myocardial perfusion were evaluated according to the thrombolysis in myocardial infarction (TIMI) flow grade and the myocardial blush grade (MBG). We found TIMI score of 3 was obtained significantly more frequently in the GW group (96%) than in the control group (80%). The MBG score of 3 was obtained also significantly greater in the GW group (65%) than in the control group (33%).CONCLUSION:Primary PCI with GW protection can significantly improve epicardial blood flow and myocardial perfusion.
[Distal perfusion cannulae in preventing limb ischemia in venous-arterial extracorporeal membrane oxygenation: a Meta-analysis].

Xiaoling Zhang,Qiang Fang,Kun Chen

DOI: https://doi.org/10.3760/cma.j.cn121430-20200920-00639

2020-01-01

Abstract:DPC can reduce the incidence of catheter-related limb ischemia in patients with VA-ECMO. Due to the small amount of studies and the influence of population heterogeneity and other factors, more large-sample and high-quality randomized controlled trial (RCT) studies are still needed.
Device-Based Approaches Targeting Cardioprotection in Myocardial Infarction: The Expanding Armamentarium of Innovative Strategies

Francisco José Romeo,Renata Mazurek,Tomoki Sakata,Spyros A Mavropoulos,Kiyotake Ishikawa

DOI: https://doi.org/10.1161/JAHA.122.026474

2022-12-06

Abstract:Coronary reperfusion therapy has played a pivotal role for reducing mortality and heart failure after acute myocardial infarction. Although several adjunctive approaches have been studied for reducing infarct size further, both ischemia-reperfusion injury and microvascular obstruction are still major contributors to both early and late clinical events after acute myocardial infarction. The progress in the field of cardioprotection has found several promising proof-of-concept preclinical studies. However, translation from bench to bedside has not been very successful. This comprehensive review discusses the importance of infarct size as a driver of clinical outcomes post-acute myocardial infarction and summarizes recent novel device-based approaches for infarct size reduction. Device-based interventions including mechanical cardiac unloading, myocardial cooling, coronary sinus interventions, supersaturated oxygen therapy, and vagal stimulation are discussed. Many of these approaches can modify ischemic myocardial biology before reperfusion and offer unique opportunities to target ischemia-reperfusion injury.
Pathophysiology and Treatment of the No-Reflow Phenomenon in ST-Segment Elevation Myocardial Infarction: Focus on Low-Dose Fibrinolysis during Primary Percutaneous Intervention

Francesco Pelliccia,Giampaolo Niccoli,Marco Zimarino,Giuseppe Andò,Italo Porto,Paolo Calabrò,Salvatore De Rosa,Felice Gragnano,Raffaele Piccolo,Elisabetta Moscarella,Enrico Fabris,Rocco Antonio Montone,Carmen Spaccarotella,Ciro Indolfi,Gianfranco Sinagra,Pasquale Perrone Filardi,Working Group of Interventional Cardiology of the Italian Society of Cardiology

DOI: https://doi.org/10.31083/j.rcm2412365

2023-12-25

Abstract:Primary percutaneous coronary intervention (PCI) is the current class I therapeutic approach to treat acute ST-elevation myocardial infarction (STEMI). While primary PCI can restore adequate flow in the infarcted artery in the majority of cases, some patients experience the 'no-reflow' phenomenon, i.e., an abnormal myocardial reperfusion occurring even after the occluded coronary artery has been opened. No-reflow occurs when microvascular obstruction arises from embolization of thrombus or components of the atheromatous plaques. These embolic materials travel downstream within the infarct-related artery at time of primary PCI, leading to compromised blood flow. Currently, no expert consensus documents exist to outline an optimal strategy to prevent or treat no-reflow. Interventional cardiologists frequently employ intracoronary adenosine, calcium channel blockers, nicorandil, nitroprusside or glycoprotein IIb/IIIa inhibitors. However, evidence suggests that these interventions consistently enhance myocardial blood flow in only a specific subset of patients experiencing no-reflow. A recent and innovative therapeutic approach gaining attention is low-dose fibrinolysis during primary PCI, which offers the potential to augment coronary flow post-myocardial revascularization.
Clinical Progress of Coronary Artery Protection by Limb Remote Ischemic Preconditioning

GAO Wei,WANG Ning-fu

DOI: https://doi.org/10.3969/j.issn.1004-3934.2011.01.019

2011-01-01

Abstract:Many clinical studies have indicated that limb remote ischemic preconditioning has a protective effect on the myocardium,with evidence of reduced area of myocardial infarction,or serum level of myocardial enzyme(troponin T or troponin Ⅰ).The protection of myocardial tissue may be related to coronary artery protection by preconditioning.Previous research has confirmed that preconditioning can reduce the dysfunction of limb artery endothelial-dependent relaxation,which is caused by endothelial injury.But the relationship between preconditioning and coronary artery function remains controversial.This review examines the current situation and recommends that advanced large scale clinical studies could clarify this issue.
Clinical Relevance of Angiographic Coronary Collaterals During Primary Coronary Intervention for Acute ST-elevation Myocardial Infarction

Shen Ying,Wu Feng,Pan Chunzang,Zhu Tianqi,Zhang Qi,Zhang Ruiyan,Ding Fenghua,Lu Lin,Hu Jian,Yang Zhenkun,Shen Weifeng,Wu Zonggui

DOI: https://doi.org/10.3760/cma.j.issn.0366-6999.20132070

IF: 6.133

2014-01-01

Chinese Medical Journal

Abstract:Background Collaterals to occluded infarct-related coronary arteries (IRA) have been observed after the onset of acute ST-elevation myocardial infarction (STEMI). We sought to investigate the impact of early coronary collateralization, as evidenced by angiography, on myocardial reperfusion and outcomes after primary percutaneous coronary intervention (PCI). Methods Acute procedural results, ST-segment resolution (STR), enzymatic infarct size, echocardiographic left ventricular function, and major adverse cardiac events (MACE) at 6-month follow-up were assessed in 389 patients with STEMI undergoing primary PCI for occluded IRA (TIMI flow grade 0 or 1) within 12 hours of symptom-onset. Angiographic coronary collateralization to the occluded IRA at first contrast injection was graded according to the Rentrop scoring system. Results Low (Rentrop score of 0 or 1) and high (Rentrop score of 2 or 3) coronary collateralization was detected in 329 and 60 patients, respectively. Patients with high collateralization more commonly had prior stable angina and right coronary artery occlusion, but less often had left anterior descending artery occlusion. At baseline, these patients presented with less extent of ST-segment elevation and lower serum levels of creatine kinase myocardial band (CK-MB) and cardiac troponin I (cTnI). Procedural success rate, STR, corrected TIMI flame count, and area under the curve of CKMB and cTnI measurements after the procedure were similar between patients with high collateralization and those with low collateralization (for all comparisons P >0.05). There were no differences in left ventricular ejection fraction and rates of MACE at 6 months according to baseline angiographic collaterals to occluded IRA. Conclusions In patients with acute STEMI undergoing primary PCI within 12 hours of symptom-onset, coronary collateralization to the occluded IRA was influenced by clinical and angiographic features. Early recruitment of collaterals limits infarct size at baseline, but has no significant impact on myocardial reperfusion after the procedure and subsequent left ventricular function and clinical outcomes.
Novel use of a stent retriever as a distal filler protection device for prevention of secondary embolization

Shohei Iijima,Yukihiro Imaoka,Satoshi Iihoshi,Shinya Kohyama

DOI: https://doi.org/10.7461/jcen.2024.E2023.08.006

2024-08-05

Abstract:Distal embolus due to mechanical thrombectomy is a frequent complication and directly results in a poor prognosis. Therefore, it is important to decrease distal embolus as much as possible in mechanical thrombectomy. EmboTrap III may be useful as a filter to prevent distal embolus in patients with a large volume of thrombus. Here, we report the results of one suggestive case and we also provide experimental data from a vessel model. The patient was a 78-year-old female who was admitted to hospital as an emergency case with chief complaints including dysarthria and left hemiplegia, including facial paralysis. She was diagnosed as large vessel occlusion-acute ischemic stroke with right tandem lesions by workup and underwent mechanical thrombectomy. A large volume of secondary thrombus due to flow stasis was assumed based around the occlusion site, and worsening of neurological symptoms was a concern due to distal embolus caused by recanalization of the cervical internal carotid artery. The SEIMLESS technique was performed under distal protection using EmboTrap III. There was no distal embolus or deterioration of neurological symptoms, and a good prognosis was achieved. This outcome suggests that PTA under distal protection using EmboTrap III may be useful for prevention of distal embolus.
Association Between Post-Balloon Angioplasty Dissection and Primary Patency in Complex Femoropopliteal Artery Disease: 2-Year Clinical Outcomes of the AcoArt I Trial

Hao Ren,Jie Liu,Jiwei Zhang,Baixi Zhuang,Weiguo Fu,Danming Wu,Feng Wang,Yu Zhao,Pingfan Guo,Wei Bi,Shenming Wang,Wei Guo

DOI: https://doi.org/10.1177/03000605211006546

2021-01-01

Journal of International Medical Research

Abstract:Objective To assess the association between post-balloon angioplasty dissection and the mid-term results of the AcoArt I trial evaluating complex femoropopliteal artery disease. Methods The outcome data for 144 patients from the AcoArt 1 trial were reanalysed. These patients were randomly divided into percutaneous transluminal angioplasty (PTA) and drug-coated balloons (DCB) groups. The primary endpoint was the primary patency (PP) rate and clinically-driven target lesion revascularisation at 24 months. Results After 24 months of follow-up, the PP rate of dissection cases in the PTA group was lower vs non-dissection cases. In patients receiving a bailout stent for dissection, the PP rate in the PTA group was lower vs the DCB group. Cox regression analysis showed that dissection decreased the PP rate; mild dissection reduced the PP rate as follows: 52%, PTA group and 19%, DCB group. With severe dissection, the PP rate reduction was as follows: 75%, PTA group and 73%, DCB group. Conclusions The mid-term follow-up showed that post-balloon angioplasty dissection reduced the PP rate in the PTA group but not in the DCB group. Additionally, in patients receiving a bailout stent for dissection, the DCB group had a better PP rate than the PTA group.
PTA of a renal artery stenosis with a new embolization protection device: Evidence of side-branch occlusion due to distal embolization — A case report

Ulrich Gerckens,Jay Yadav,Sascha Rowold,Eberhard Grube

DOI: https://doi.org/10.1055/s-0031-1276329

2002-12-01

International Journal of Angiology

Abstract:Percutaneous angioplasty (PTA) and stenting is established and beneficial for treatment of hypertension caused by renal artery stenosis. The incidence and clinical implications of distal embolisation by liberation of atherosclerotic plaque material during renal intervention is unknown. We report on our first clinical application of a new embolization protection device (AngioGuard) in one patient with significant left renal artery stenosis. The AngioGuard consists of a 0.014 guidewire with a emboli filter basket at the distal part to capture and retreat embolic plaque debris. After device placement distal to the lesion we performed the PTA and stenting of the lesion in a standard manner. During the intervention we observed the occlusion of a renal side-branch caused by the completely filled emboli protection basket. The captured debris could be successful if extracted with the AngioGuard wire and normal blood-flow (TIMI 3) without filling defects was reestablished. The macroscopically visible particles measured up to 2.1×1.8 mm and were histologically analysed.
Balloon Deflation Strategy During Primary Percutaneous Coronary Intervention in Acute ST-Segment Elevation Myocardial Infarction: A Randomized Controlled Clinical Trial and Numerical Simulation-Based Analysis.

Jun Gu,Yang Zhuo,Tian-jiao Liu,Jie Li,Zhao-fang Yin,Zuo-jun Xu,Li Fan,Qing He,Kan Chen,Hua-su Zeng,Xiao-fei Wang,Yu-qi Fan,Jun-feng Zhang,Fu-you Liang,Chang-qian Wang

DOI: https://doi.org/10.1155/2020/4826073

IF: 1.99

2020-01-01

Cardiology Research and Practice

Abstract:BACKGROUND:Primary percutaneous coronary intervention (PCI) is the best available reperfusion strategy in patients with acute ST-segment elevation myocardial infarction (STEMI). However, PCI is associated with a serious problem known as no-reflow phenomenon, resulting in poor clinical and functional outcomes. This study aimed to compare the influences of different balloon deflation velocity on coronary flow and cardiovascular events during primary PCI in STEM as well as transient hemodynamic changes in in vitro experiments. Method and Results. 211 STEMI patients were randomly assigned to either a rapid or a slow balloon deflation group during stent deployment. The primary end point was coronary flow at the end of PCI procedure, and secondary end points included myocardial infarct size. Transient hemodynamic changes were evaluated through an in vitro experimental apparatus and a computer model. In clinical practice, the level of corrected TIMI frame count (cTFC) in slow balloon deflation after primary PCI was significantly lower than that of rapid balloon deflation, which was associated with smaller infarct size. Numerical simulations revealed that the rapid deflation led to a sharp acceleration of flow in the balloon-vessel gap and a concomitant abnormal rise in wall shear stress (WSS).CONCLUSION:This randomized study demonstrated that the slow balloon deflation during stent implantation improved coronary flow and reduced infarct size in reperfused STEMI. The change of flow in the balloon-vessel gap and WSS resulted from different balloon deflation velocity might be partly accounted for this results.
The diagonal branches and outcomes in patients with anterior ST- elevation myocardial infarction

Shuning Zhang,Xin Deng,Wenlong Yang,Liping Xia,Kang Yao,Hao Lu,Lei Ge,Li Shen,Aijun Sun,Yunzeng Zou,Juying Qian,Junbo Ge

DOI: https://doi.org/10.1186/s12872-020-01386-4

IF: 2.174

2020-01-01

BMC Cardiovascular Disorders

Abstract:Background The management of diagonal branch (D) occlusion is still controversary. The association between the flow loss of D and the prognosis remains unclear. We aim to detect the impact of D flow on cardiac function and clinical outcomes in patients with anterior ST-segment elevation myocardial infarction (STEMI). Methods Patients with anterior STEMI undergoing primary percutaneous coronary intervention (PCI) at our clinic between October 2015 and October 2018were reviewed. Anterior STEMI due to left anterior descending artery (LAD) occlusion with or without loss of the main D flow (TIMI grade 0–1 or 2–3) was enrolled in the analysis. The short- and long-term incidence of major adverse cardiac events (MACEs, a composite of all-cause death, target vessel revascularization and reinfarction) and left ventricular ejection fraction (LVEF) were analyzed. Results A total of 392 patients (mean age of 63.9 years) with anterior STEMI treated with primary PCI was enrolled in the study. They were divided into two groups, loss (TIMI grade 0–1, n = 69) and no loss (TIMI grade2–3, n = 323) of D flow, before primary PCI. Compared with the group without loss of D flow, the group with loss of D flow showed a lower LVEF post PCI (41.0% vs. 48.8%, p = 0.003). Meanwhile, loss of D flow resulted in the higher in-hospital, one-month, and 18-month incidence of MACEs, especially in all-cause mortality (all p < 0.05). Landmark analysis further indicated that the significant differences in 18-month outcomes between the two groups mainly resulted from the differences during the hospitalization. In addition, multivariate Cox proportional hazards analysis found that D flow loss before primary PCI was independent factor predicting short- and long-term outcomes in patients with anterior STEMI. Conclusion Loss of the main D flow in anterior STEMI patients was independently associated with the higher in-hospital incidences of MACEs and all-cause death as well as the lower LVEF.
Association Between Tissue Characteristics of Coronary Plaque and Distal Embolization after Coronary Intervention in Acute Coronary Syndrome Patients: Insights from a Meta-Analysis of Virtual Histology-Intravascular Ultrasound Studies

Song Ding,Longwei Xu,Fan Yang,Lingcong Kong,Yichao Zhao,Lingchen Gao,Wei Wang,Rende Xu,Heng Ge,Meng Jiang,Jun Pu,Ben He

DOI: https://doi.org/10.1371/journal.pone.0106583

IF: 3.7

2014-01-01

PLoS ONE

Abstract:BACKGROUND AND OBJECTIVES: The predictive value of plaque characteristics assessed by virtual histology-intravascular ultrasound (VH-IVUS) including fibrous tissue (FT), fibrofatty (FF), necrotic core (NC) and dense calcium (DC) in identifying distal embolization after percutaneous coronary intervention (PCI) is still controversial. We performed a systematic review and meta-analysis to summarize the association of pre-PCI plaque composition and post-PCI distal embolization in acute coronary syndrome patients. METHODS: Studies were identified in PubMed, OVID, EMBASE, the Cochrane Library, the Current Controlled Trials Register, reviews, and reference lists of relevant articles. A meta-analysis using both fixed and random effects models with assessment of study heterogeneity and publication bias was performed. RESULTS: Of the 388 articles screened, 10 studies with a total of 872 subjects (199 with distal embolization and 673 with normal flow) met the eligibility of our study. Compared with normal flow groups, significant higher absolute volume of NC [weighted mean differences (WMD): 5.79 mm3, 95% CI: 3.02 to 8.55 mm3; p<0.001] and DC (WMD: 2.55 mm3, 95% CI: 0.22 to 4.88 mm3; p = 0.03) were found in acute coronary syndrome patients with distal embolization. Further subgroup analysis demonstrated that the predictive value of tissue characteristics in determining distal embolization was correlated to clinical scenario of the patients, definition of distal embolization, and whether the percutaneous aspiration thrombectomy was applied. CONCLUSION: Our study that pooled current evidence showed that plaque components were closely related to the distal embolization after PCI, especially the absolute volume of NC and DC, supporting further studies with larger sample size and high-methodological quality.
A fresh look at coronary microembolization

Petra Kleinbongard,Gerd Heusch

DOI: https://doi.org/10.1038/s41569-021-00632-2

IF: 49.421

2021-11-16

Nature Reviews Cardiology

Abstract:Mechanical stress from haemodynamic perturbations or interventional manipulation of epicardial coronary atherosclerotic plaques with inflammatory destabilization can release particulate debris, thrombotic material and soluble substances into the coronary circulation. The physical material obstructs the coronary microcirculation, whereas the soluble substances induce endothelial dysfunction and facilitate vasoconstriction. Coronary microvascular obstruction and dysfunction result in patchy microinfarcts accompanied by an inflammatory reaction, both of which contribute to progressive myocardial contractile dysfunction. In clinical studies, the benefit of protection devices to retrieve atherothrombotic debris during percutaneous coronary interventions has been modest, and the treatment of microembolization has mostly relied on antiplatelet and vasodilator agents. The past 25 years have witnessed a relative proportional increase in non-ST-segment elevation myocardial infarction in the presentation of acute coronary syndromes. An associated increase in the incidence of plaque erosion rather than rupture has also been recognized as a key mechanism in the past decade. We propose that coronary microembolization is a decisive link between plaque erosion at the culprit lesion and the manifestation of non-ST-segment elevation myocardial infarction. In this Review, we characterize the features and mechanisms of coronary microembolization and discuss the clinical trials of drugs and devices for prevention and treatment.

cardiac & cardiovascular systems

Distal Protection Devices During Primary Angioplasty in Acute Myocardial Infarction

Effect of a Distal Protection Device on Epicardial Blood Flow and Myocardial Blush in Primary Percutaneous Coronary Intervention

Clinical Observation of Distal Protection Device During Primary Angioplasty in Acute Myocardial Infarction

Myocardial Protection in Patients with Acute Myocardial Infarction Using Distal Occlusion Balloon Protection Device

Application of the Vascular Distal Protection Device in Percutaneous Coronary Interventional Therapy in Patients with Acute ST Segment Elevation Myocardial Infarction

The Application of AngioguardTM Distal Protection Device in the Emergency Percutaneous Coronary Intervention in Patients with Acute ST Segment Elevation Myocardial Infarction

Distal embolic filter protection during debulking treatment of peripheral artery disease

Effect of a Distal Protection Device on Epicardial Blood Flow and Myocardial Perfusion in Primary Percutaneous Coronary Intervention

[Distal perfusion cannulae in preventing limb ischemia in venous-arterial extracorporeal membrane oxygenation: a Meta-analysis].

Device-Based Approaches Targeting Cardioprotection in Myocardial Infarction: The Expanding Armamentarium of Innovative Strategies

Pathophysiology and Treatment of the No-Reflow Phenomenon in ST-Segment Elevation Myocardial Infarction: Focus on Low-Dose Fibrinolysis during Primary Percutaneous Intervention

Clinical Progress of Coronary Artery Protection by Limb Remote Ischemic Preconditioning

Clinical Relevance of Angiographic Coronary Collaterals During Primary Coronary Intervention for Acute ST-elevation Myocardial Infarction

Novel use of a stent retriever as a distal filler protection device for prevention of secondary embolization

Association Between Post-Balloon Angioplasty Dissection and Primary Patency in Complex Femoropopliteal Artery Disease: 2-Year Clinical Outcomes of the AcoArt I Trial

PTA of a renal artery stenosis with a new embolization protection device: Evidence of side-branch occlusion due to distal embolization — A case report

Balloon Deflation Strategy During Primary Percutaneous Coronary Intervention in Acute ST-Segment Elevation Myocardial Infarction: A Randomized Controlled Clinical Trial and Numerical Simulation-Based Analysis.

The diagonal branches and outcomes in patients with anterior ST- elevation myocardial infarction

Association Between Tissue Characteristics of Coronary Plaque and Distal Embolization after Coronary Intervention in Acute Coronary Syndrome Patients: Insights from a Meta-Analysis of Virtual Histology-Intravascular Ultrasound Studies

A fresh look at coronary microembolization